BR0314185A - Derivados da quinolil propil piperidina e sua utilização como agentes antimicrobianos. - Google Patents

Derivados da quinolil propil piperidina e sua utilização como agentes antimicrobianos.

Info

Publication number
BR0314185A
BR0314185A BR0314185-3A BR0314185A BR0314185A BR 0314185 A BR0314185 A BR 0314185A BR 0314185 A BR0314185 A BR 0314185A BR 0314185 A BR0314185 A BR 0314185A
Authority
BR
Brazil
Prior art keywords
alkyl
cooh
alkoxy
substituted
cyc
Prior art date
Application number
BR0314185-3A
Other languages
English (en)
Inventor
Eric Bacque
Antony Bigot
Youssef El-Ahmad
Jean-Luc Malleron
Serge Mignani
Baptiste Ronan
Michel Tabart
Fabrice Viviani
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of BR0314185A publication Critical patent/BR0314185A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

"DERIVADOS DA QUINOLIL PROPIL PIPERIDINA E SUA UTILIZAçãO COMO AGENTES ANTIMICROBIANOS". A presente invenção refere-se a um derivado de quinolil piperidina, de fórmula geral (I) na qual: R~ 1a~ é hidrogênio, halogênio, hidróxi, amino, alcoilamino, dialcoilamino, hidroxiamino, alcoiloxiamino ou alcoil alcoilóxi amino e R~ 1b~ é hidrogênio, ou R~ 1a~ e R~ 1b~ formam um grupo oxo; R~ 2~ é carbóxi, carboximetila ou hidroximetila; R~ 3~ é alcoíla substituída por um feniltio, eventualmente substituído por halogênio, hidróxi, alcoíla, alcoilóxi, trífluorometila, trifluorometóxi, carbóxi, alcoiloxicarbonila, ciano ou amino, por um cicloalcoiltio (3 a 7 cadeias) eventualmente substituído por halogênio ou trifluorometila, ou por heteroariltio de (5 a 6 cadeias e 1 a 4 heteroátomos selecionados dentre N, O e S), eventualmente substituído por halogênio, hidróxi, alcoíla, alcoilóxi, trifluorometila, trifluorometóxi, carbóxi, alcoiloxicarbonila, ciano ou amino ou R~ 3~ representa um radical propargila substituído por fenila ou heteroarila, tais como definidos acima, R~ 4~ é alcoíla, alcenil-CH~ 2~- ou alcinil-CH~ 2~-, cicloalquila ou cicloalcoil alcoíla, sob suas diferentes formas isómeras separadas ou em misturas, assim como seus sais, seu processo e intermediárias de preparo e as composições que os contêm. Esses novos derivados são potentes agentes antibacterianos.
BR0314185-3A 2002-09-11 2003-09-10 Derivados da quinolil propil piperidina e sua utilização como agentes antimicrobianos. BR0314185A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0211213A FR2844268B1 (fr) 2002-09-11 2002-09-11 Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent
PCT/FR2003/002687 WO2004024713A1 (fr) 2002-09-11 2003-09-10 Derives de la quinolyl propyl piperidine et leur utilisation en tant qu'agents antimicrobiens

Publications (1)

Publication Number Publication Date
BR0314185A true BR0314185A (pt) 2005-08-09

Family

ID=31725984

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0314185-3A BR0314185A (pt) 2002-09-11 2003-09-10 Derivados da quinolil propil piperidina e sua utilização como agentes antimicrobianos.

Country Status (22)

Country Link
US (1) US6841562B2 (pt)
EP (1) EP1539734B1 (pt)
JP (1) JP2006500403A (pt)
KR (1) KR20050042196A (pt)
CN (1) CN100415736C (pt)
AT (1) ATE319705T1 (pt)
AU (1) AU2003278297A1 (pt)
BR (1) BR0314185A (pt)
CA (1) CA2498628A1 (pt)
DE (1) DE60303954T2 (pt)
DK (1) DK1539734T3 (pt)
EA (1) EA009769B1 (pt)
ES (1) ES2256783T3 (pt)
FR (1) FR2844268B1 (pt)
MA (1) MA27433A1 (pt)
MX (1) MXPA05002655A (pt)
NO (1) NO20051754L (pt)
OA (1) OA12922A (pt)
PT (1) PT1539734E (pt)
RS (1) RS20050212A (pt)
TN (1) TNSN05069A1 (pt)
WO (1) WO2004024713A1 (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
EP2181996A1 (en) * 2002-01-29 2010-05-05 Glaxo Group Limited Aminopiperidine derivatives
EP1470131A2 (en) 2002-01-29 2004-10-27 Glaxo Group Limited Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
AR040335A1 (es) * 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de ciclohexano o ciclohexeno, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende, procedimiento y compuestos intermediarios de utilidad para preparar dicho compuesto
TW200409637A (en) * 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
AU2003291227A1 (en) 2002-11-05 2004-06-07 Smithkline Beecham Corporation Antibacterial agents
EP1560821B8 (en) 2002-11-05 2010-05-19 Glaxo Group Limited Antibacterial agents
TW200427688A (en) * 2002-12-18 2004-12-16 Glaxo Group Ltd Antibacterial agents
GB2413863A (en) * 2004-05-08 2005-11-09 Ibm Method and system for distribution of information
US20070254872A1 (en) * 2004-07-08 2007-11-01 Glaxo Group Limited Antibacterial Agents
DE602005021133D1 (de) * 2004-10-05 2010-06-17 Actelion Pharmaceuticals Ltd Neue piperidin-antibiotika
JP2008528598A (ja) 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
WO2006081178A2 (en) * 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
WO2006081182A2 (en) 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
US7709472B2 (en) 2005-01-25 2010-05-04 Glaxo Group Limited Antibacterial agents
WO2006081289A2 (en) * 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
MY150958A (en) * 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
JP2009532423A (ja) 2006-04-06 2009-09-10 グラクソ グループ リミテッド 抗菌剤としてのピロロ−キノキサリノン誘導体
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
US20100144717A1 (en) * 2006-12-15 2010-06-10 Janelle Comita-Prevoir 2-quinolinone and 2-quinoxalinone-derivatives and their use as antibacterial agents
US8389524B2 (en) * 2007-04-20 2013-03-05 Glaxo Group Limited Tricyclic nitrogen containing compounds as antibacterial agents
EP2080761A1 (en) 2008-01-18 2009-07-22 Glaxo Group Limited Compounds
FR2936798B1 (fr) * 2008-10-03 2012-09-28 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens.
FR2936951B1 (fr) * 2008-10-10 2010-12-03 Novexel Nouvelles combinaisons de composes heterocycliques azotes antibacteriens avec d'autres composes antibacteriens et leur utilisation comme medicaments
FR2937034B1 (fr) * 2008-10-10 2012-11-23 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens
US20110275661A1 (en) 2008-10-17 2011-11-10 Glaxo Group Limited Tricyclic nitrogen compounds used as antibacterials
US8318940B2 (en) 2009-01-15 2012-11-27 Glaxo Group Limited Naphthyridin-2 (1 H)-one compounds useful as antibacterials
PE20170501A1 (es) 2014-08-22 2017-04-27 Glaxosmithkline Ip Dev Ltd Un procedimiento que comprende compuestos que administran a un sujeto infectado con neisseria gonorrhoeae
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
KR102231872B1 (ko) * 2019-10-04 2021-03-26 성균관대학교산학협력단 포스포늄일리드를 이용한 디아진-n-옥사이드의 위치선택적 알킬화 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT198900008A (es) * 1988-01-29 1990-07-17 Derivados de quinolina, quinazolina y cinolina.
US6117884A (en) * 1997-07-31 2000-09-12 Daeuble; John 4-substituted quinoline derivatives having fungicidal activity
AU2437900A (en) * 1999-01-20 2000-08-07 Smithkline Beecham Plc Piperidinylquinolines as protein tyrosine kinase inhibitors
FR2798656B1 (fr) * 1999-09-17 2004-12-17 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent
US6603005B2 (en) * 2000-11-15 2003-08-05 Aventis Pharma S.A. Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them
FR2816618B1 (fr) * 2000-11-15 2002-12-27 Aventis Pharma Sa Derives heterocyclylalcoyl piperidine, leur preparation et les compositions qui les contiennent
FR2822154B1 (fr) * 2001-03-13 2005-10-21 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent

Also Published As

Publication number Publication date
US6841562B2 (en) 2005-01-11
MA27433A1 (fr) 2005-07-01
EA009769B1 (ru) 2008-04-28
NO20051754D0 (no) 2005-04-08
EP1539734B1 (fr) 2006-03-08
DK1539734T3 (da) 2006-06-06
RS20050212A (en) 2007-09-21
CN100415736C (zh) 2008-09-03
US20040082610A1 (en) 2004-04-29
OA12922A (fr) 2006-10-13
CN1681801A (zh) 2005-10-12
ATE319705T1 (de) 2006-03-15
ES2256783T3 (es) 2006-07-16
AU2003278297A1 (en) 2004-04-30
EA200500474A1 (ru) 2005-08-25
FR2844268A1 (fr) 2004-03-12
CA2498628A1 (fr) 2004-03-25
EP1539734A1 (fr) 2005-06-15
PT1539734E (pt) 2006-05-31
WO2004024713A1 (fr) 2004-03-25
NO20051754L (no) 2005-04-08
FR2844268B1 (fr) 2004-10-22
KR20050042196A (ko) 2005-05-04
MXPA05002655A (es) 2005-09-08
DE60303954T2 (de) 2006-12-07
JP2006500403A (ja) 2006-01-05
DE60303954D1 (de) 2006-05-04
TNSN05069A1 (fr) 2007-05-14

Similar Documents

Publication Publication Date Title
TNSN05069A1 (fr) Derives de la quinolyl propyl piperidine et leur utilisation en tant qu'agents antimicrobiens
ECSP055644A (es) Derivados de la quinolil-propil-piperidina y su utilización
RU2404982C2 (ru) Применение соединений пирролохинолина для уничтожения клинически латентных микроорганизмов
AR049739A1 (es) Derivados de aril-piridina
EA200400305A1 (ru) 2,4,5-тризамещенные производные тиазолила и их противовоспалительная активность
NO20070555L (no) Kinazolinonderivater som parp-inhibitorer
ME01089B (me) Derivat benzimidazola i njegova upotreba kao antagonista receptora aii
DE60124761D1 (de) Chinoline und deren in der 4-stellung durch eine piperazinhaltige gruppe substituierte nitrogenierte derivate und deren verwendung als antibakterielle mittel
ATE450532T1 (de) Pyridinyl- oder pyrimidinylthiazole mit proteinkinasehemmender wirkung
PE20061124A1 (es) Compuestos y derivados de dibencil amina
PE20060243A1 (es) Derivados de 4-amino insustituido-5-(4-urea-fenil)-pirrolotriazina
AR049699A1 (es) Derivados de pirimidina
DE602006004865D1 (de) Antimykotische mittel
NO20065902L (no) 3-{4-(pyridin-3-yl)fenyl}-5-(1H-,1,2,3-triazol-1-ylmetyl)-1,3-oksazolidin-2-oner som antibakterielle midler
TR200201205T2 (tr) N-ikame edilmiş karbamoiloksialkil-azolyum türevleri.
MXPA05010816A (es) Derivados de 4-(4- (heterociclilalcox}fenil)- 1-(heterociclil- carbonil) piperidina y compuestos relacionados como antagonistas de h3 de la histamina para el tratamiento de enfermedades neurologicas tales como alzheimer.
NO20063330L (no) Amidderivater med en syklopropylaminokarbonylsubstituent som er nyttige som cytokininhibitorer
NO20061832L (no) Karboksamidderivat av amidtype
ATE277042T1 (de) Antimikrobielle 4-oxochinolizine mit 2- pyridongerüsten als teilstruktur
MX2009003051A (es) Derivados de quinolinona.
MXPA05010986A (es) Compuestos de n-[(piperazinil)hetaril]arilsulfonamida con afinidad para el receptor d3 de la dopamina.
ATE282037T1 (de) Benzoxazolderivate als tnf und pde iv inhibitoren
TW200504059A (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
NO20076037L (no) Nye tiazolidinoner uten basisk nitrogen, deres fremstilling og anvendelse som farmasoytiske midler
MEP17408A (en) N-(heterocyclyl)benzene or pyridine sulphonamides as antithrombotic agents and anticoagulants

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]